Introduction
============

Elderly people are the greatest consumers of drugs in western countries: the number of daily used drugs rises from 2.0 ± 1.9 for people aged 65--74 years to 2.5 ± 2.0 for people aged 75 and over ([@b9]). Polypathology, a strictly age-correlated phenomenon, is likely to be the main determinant of drug consumption. However, both over-prescribing and improper prescribing has been reported and seems to contribute to the age-related increase in the prevalence of adverse drug reactions (ADRs) ([@b24]; [@b8]). On average, ADRs account for 3%--13% of all the admissions ([@b5]; [@b20]; [@b24]; [@b29]) and complicate 5%--20% of the stays of patients over 65 years ([@b25]; [@b33]; [@b11]). Thus, any effort should be made to limit and to rationalize drug prescription. Pursuing such an objective requires that physicians be aware of the dynamics at the basis of polypharmacy in the current clinical practice. In this perspective, it should be clarified whether the hospitalization moderates or promotes drug utilization. Finally, the appropriateness of drug prescription should be also assessed besides quantifying drug use. The present study has been undertaken to assess both correlates of polypharmacy, as estimated on discharge prescriptions from wards of general medicine and geriatrics, and appropriate prescription. A further objective was to investigate the effects of hospitalization on the number of prescribed drugs in the whole population studied and in groups identified by the most prevalent diseases.

Methods
=======

Patients
--------

The present study uses data from a large observational study group, the Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA), a collaborative group based in community and university hospitals located throughout Italy. GIFA periodically surveyed drug consumption, occurrence of ADRs, and quality of hospital care from 1988 to 1998. We used data on patients consecutively admitted to the 24 participating geriatric or internal medicine wards during the 4-month survey carried out in 1998. We did not use data collected in previous years to minimize the differences in actual prescribing practice. Methods of the GIFA have been previously described ([@b7]). Briefly, a study physician with specific training completed a questionnaire for each patient at admission to hospital and updated it daily. Data recorded included sociodemographic characteristics, medical variables, complete blood count, neuropsychological and physical function variables.

Overall, 3010 patients were enrolled in the survey period. We excluded patients who died during hospital stay (n = 117) and those with missing data for any of the variables of interest (n = 428, including people with cognitive deficit severe enough to make the completion of geriatric assessment impossible), with a final sample of 2465 patients (839 patients \<65 years; 1035 patients 65--79 years; 591 patients 80 years or more). Patients who died during their stay differed from that included in the analysis for a greater prevalence of older age (80 years or more: 57.3% vs 24.0%, p \< 0.001), congestive heart failure (CHF) (29.1% vs 16.1%, p \< 0.001), and renal failure (15.4% vs 6.9%, p \< 0.01). The use of more than 3 drugs prior to admission was similar in both included and excluded patients (63.7% and 63.5%, respectively).

The outcome of the study was having more than 6 drugs prescribed at discharge from the acute care hospital, where 6 corresponds to the 75th percentile of the number of prescribed drugs distribution. Information on pharmacological therapy prior to the hospitalization was collected by asking patients or their relatives to provide all drug samples and their respective prescriptions. This procedure was made according to a previously validated method ([@b7]). Drugs were coded by Anatomical and Therapeutical Classification (ATC) ([@b28]).

Variables specifically considered in this study were age, gender, and type of ward. The presence of depressive symptoms was ascertained using the 15-item Geriatric Depression Scale (GDS), and patients with a GDS score greater than 5 were considered as depressed ([@b19]). Functional and cognitive capabilities were measured by Basic and Instrumental Activities of Daily Living (BADL and IADL) scale ([@b15]), and Hodgkinson Abbreviated Mental Test (AMT) ([@b14]), respectively. Patients having an AMT score of 7 or less were considered cognitively impaired ([@b31]). Diagnoses were coded according to International Classification of Diseases, Clinical Modification 9th revision (ICD-9 CM) ([@b37]). Having more than 4 diagnoses was considered as an index of cumulative comorbidity. Furthermore, highly prevalent age-related chronic conditions that may increase the consumption of drugs (hypertension, diabetes mellitus, congestive heart failure, coronary artery disease, cerebral vascular disease, peripheral vascular disease, chronic obstructive pulmonary disease (COPD), chronic renal failure, hepatic insufficiency, and malignancies) were also considered as potential correlates. The number of drugs taken in the 30 days before hospital admission was also considered in the analysis, and information on drug therapy in people with cognitive impairment was collected by caregivers.

Finally, the occurrence of ADRs before admission and during hospital stay were also considered as potential correlates of the outcomes. The study researcher evaluated the participants daily and screened for any new event that could possibly be due to an ADR. For every such event, a dedicated section of the study questionnaire was completed, including the description of the ADR, the suspected drug(s), the severity of the ADR ranging from mild to life-threatening, and an algorithm that provided a graded probability of cause-effect relationship between the suspected drug(s) and the ADR ([@b23]).

Procedures conformed to guidelines provided by the Catholic University Ethical Committee.

Statistical analysis
--------------------

We used contingency tables to compare the demographic and clinical characteristics of patients grouped according to whether they had less than 7, or more than 6 drugs prescribed at discharge. We then built multivariable logistic regression model to evaluate the individual association with polypharmacy of the characteristics whose prevalence was different between the two groups. Since the presence of depressive symptoms has been previously reported to increase the number of prescribed drugs ([@b3]), the analysis was also repeated after excluding anxiolytic and antidepressant drugs from the definition of polypharmacy. In this secondary analysis we excluded also anxiolytics because of the high prevalence of anxious symptoms in elderly depressed patients ([@b18]).

The effects of hospitalization on the number of prescribed drugs in the whole population studied and in groups identified by the most prevalent mean diseases were also investigated by comparing the number of drugs taken before admission and prescribed at discharge. Wilcoxon's signed rank test was used in this analysis because data were not normally distributed.

To verify whether inappropriate prescribing could contribute to increase the number of prescribed drugs at discharge, we also investigated the prevalence of selected clinical conditions in patients having digoxin, diuretics, antithrombotics, or inhaled bronchodilators prescribed before admission, during stay or at discharge. The indications we considered in the analysis were heart failure or atrial fibrillation for digoxin; heart failure, hypertension, and renal or hepatic insufficiency for diuretics; atrial fibrillation, congestive heart failure, coronary artery disease, peripheral or cerebral vascular disease for antithrombotics; COPD or asthma for inhaled bronchodilators. Finally, to distinguish the impact of drugs presumably prescribed for a brief period to complete a short term course from that of drugs generally prescribed for long-term therapies on polypharmacy at discharge, we assessed the prevalence of prescription of antibiotics or steroids and that of antihypertensive or hypoglycemic agents. All analyses were performed using SPSS V10.0 (SPSS Inc., Chicago, IL, USA).

Results
=======

Of the 2465 patients considered in the analysis, 532 (21.6%) had reduced, 517 (21.0%) had unchanged, and 1,416 (57.4%) had increased number of drugs at discharge with respect to the month prior to admission. The number of patients already taking more than 6 drugs before admission was 172 (7.0%). The outcome was present in 489 (19.8%) patients.

Demographic and clinical characteristics of patients divided according to the number of drugs prescribed at discharge from the acute care hospital are shown in [Table 1](#tbl1){ref-type="table"}. Patients having more than 6 drugs prescribed were slightly older and more frequently female than patients having less than 7 drugs prescribed. Having more than 4 diagnoses was more frequent among those taking more drugs, as were the diagnoses of congestive heart failure, coronary artery disease, hypertension, diabetes mellitus, peripheral vascular disease, COPD, and renal insufficiency. Physical dependency and depressive symptoms, but not cognitive impairment, were more prevalent among patients having 7 or more drugs prescribed at discharge. A history of ADRs prior to admission was negatively correlated with a discharge prescription of over 6 drugs, whereas in hospital ADRs qualified as a positive correlate. Finally, the greater the number of drugs taken at home, the greater the number of drugs prescribed at discharge.

###### 

Demographic and clinical characteristics of patients divided according to the number of drugs prescribed at discharge

                                          Number of drugs at discharge          
  --------------------------------------- ------------------------------ ------ ---------
  Age                                                                           \>0.001
   \<65                                   36.3                           24.7   
   65--79                                 40.6                           47.6   
   ≥80                                    23.1                           27.6   
  Gender (Male)                           57.5                           52.8   0.056
  Type of ward                                                                  0.112
   Geriatric                              65.7                           69.5   
   Medicine                               34.3                           30.5   
  No of diagnoses \>4                     40.5                           69.9   \<0.001
  Congestive heart failure                12.3                           31.7   \<0.001
  Coronary artery disease                 28.0                           40.1   \<0.001
  Hypertension                            36.9                           45.6   \<0.001
  Diabetes Mellitus                       15.2                           36.6   \<0.001
  Cerebral vascular disease               13.6                           14.3   0.665
  Peripheral vascular disease             4.3                            7.4    0.004
  Chronic obstructive pulmonary disease   9.6                            19.4   \<0.001
  Renal insufficiency                     4.9                            14.9   \<0.001
  Hepatic insufficiency                   7.1                            7.4    0.547
  Malignancies                            6.5                            7.2    0.617
  Dependency in at least 1 BADL           7.6                            14.1   \<0.001
  Dependency in at least 1 IADL           33.1                           52.1   \<0.001
  Cognitive impairment                    19.2                           17.0   0.253
  Depression                              25.9                           42.1   \<0.001
  ADRs before admission                   3.8                            1.6    0.016
  ADRs during stay                        10.0                           13.7   0.017
  No of drugs before admission\> 3        57.4                           89.4   \<0.001

**Abbreviations**: ADRs, adverse drug reactions; BADL, basic activities of daily living; IADL, instrumental activities of daily living.

Multivariable logistic regression model showed that age per se was not significantly associated with the outcome. Polypharmacy prior to admission, cumulative comorbidity, diabetes mellitus, congestive heart failure, COPD, and renal insufficiency were significant correlates of the number of prescribed drugs at discharge. Depressive symptoms also were a significant independent correlate of the outcome, while the occurrence of ADRs prior to admission was the only negative correlate ([Table 2](#tbl2){ref-type="table"}). Depressive symptoms remained significantly associated with the outcome also after excluding antidepressant and anxiolytic agents from the computation of the number of prescribed drugs (OR = 1.47; 95% CI = 1.18--2.01).

###### 

Summary logistic regression model of selected variables to having more than 6 drugs prescribed at discharge

                                          OR     95% CI
  --------------------------------------- ------ ------------
  Age                                            
   \<65                                   1.0    
   65--79                                 0.97   0.73--1.28
  ≥80                                     0.87   0.63--1.21
  Gender (Males)                          0.81   0.64--1.02
  No of diagnoses\>4                      1.81   1.40--2.32
  Congestive heart failure                2.05   1.57--2.68
  Coronary artery disease                 1.24   0.97--1.58
  Hypertension                            1.05   0.83--1.32
  Diabetes Mellitus                       2.65   2.07--3.41
  Peripheral vascular disease             1.36   0.86--2.14
  Chronic obstructive pulmonary disease   2.09   1.53--2.85
  Renal insufficiency                     1.88   1.29--3.03
  Dependency in at least 1 BADL           1.33   0.92--1.93
  Dependency in at least 1 IADL           1.19   0.93--1.52
  Depressive symptoms                     1.67   1.32--2.12
  ADRs before admission                   0.22   0.09--0.51
  ADRs during stay                        1.41   0.97--2.08
  No of drugs before admission\>3         4.32   3.13--5.96

**Abbreviations**: ADRs, adverse drug reactions; BADL, basic activities of daily living; IADL, instrumental activities of daily living.

In patients treated with digoxin, the prevalence of recognized indications ranged from 58.4% (at home) to 65.1% (discharge prescription). In patients treated with diuretics, antithrombotics, or inhaled bronchodilators, the corresponding figures were 66.8%, 79.5%, and 69.1% before admission, and 71.9%, 80.5%, and 69.3% at discharge, respectively ([Figure 1](#fig1){ref-type="fig"}).

![Prevalence of correct indications in patients having digoxin (atrial fibrillation or congestive heart failure), diuretics (hypertension, congestive heart failure, renal or hepatic insufficiency), antithrombotics (atrial fibrillation, congestive heart failure, coronary artery disease, peripheral or cerebral vascular disease, pulmonary embolism or thrombophlebitis) or inhaled bronchodilators (chronic obstructive pulmonary disease, asthma or rinhitis) prescribed at home, during hospital stay, and at discharge, respectively.](tcrm0301-197-01){#fig1}

Finally, the use of antibiotics or systemic steroids, ie, drugs which are likely to be prescribed for a brief period to complete a short term course, rose from 4.2% and 4.2% before admission to 8.9% and 6.0% at discharge, respectively. However, the use of drugs prescribed to treat a chronic condition, such as antihypertensives, also increased from 59.0% prior to admission to 66.9% at discharge ([Figure 2](#fig2){ref-type="fig"}).

![Use of antibiotics or systemic steroids (upper panel), and of antihypertensive or hypoglycemic agents (lower panel), before admission, during hospital stay, and at discharge.](tcrm0301-197-02){#fig2}

Discussion
==========

The present study shows that age per se does not carry a higher risk of polypharmacy, while age-related polypathology does. Similar results have been previously obtained: comorbid conditions, such as diabetes and chronic lung disease, but not older age, predict a greater complexity and cost of drugs regimen in elderly patients with heart failure ([@b21]). Our study also shows that the appropriateness of the prescription is frequently questionable and the hospitalization results in a considerable increase in drug prescription (with regard to previous home therapy). These findings confirm the high prevalence of inappropriate prescribing observed in previous reports from the GIFA study ([@b26], [@b27]).

The link between polypathology and polypharmacy is an obvious one, mainly for diseases such as diabetes mellitus or COPD, posing several therapeutic problems which are partly secondary to a variety of complications. However, the lack of a reliable explanation to the use of selected drugs, at least on the basis of current therapeutic guidelines, suggests that over-prescription is a common problem in elderly population. Indeed, there is evidence that diuretics are frequently prescribed to treat edema secondary to venous stasis or chronic respiratory failure ([@b36]; [@b16]), whereas physical measures and the correction of blood gas derangement should be the respective therapeutic approach ([@b1]; [@b17]). Furthermore, both leg edema and COPD have been associated with undue digitalis use ([@b4]; [@b2]). Symptoms such as dyspnea and asthenia, have also been reported to justify the use of digitalis in the absence of a well defined pathogenetic interpretation ([@b12]). Thus, both over prescription and undue prescription seem to characterize the overall pharmacological therapy of the elderly.

Depressive symptoms are significantly associated with polypharmacy even after having excluded antidepressants and anxiolytics from the computation. This finding replicates results by [@b32]) and [@b3]), but it is of special concern in an elderly population, which is exposed to a greater risk of ADRs. While the complaint of disparate symptoms likely underlies this association, a lack of attention to the elderly patient might contribute to it. Indeed, general practitioners have been reported to spend 12.4 and 11.2 minutes for visiting an adult (45--64 years old) and an elderly (75 or older) patient, respectively ([@b30]). Depression is highly prevalent in the elderly ([@b34]), mainly in women, and, thus, physicians should be aware of the problem and spend more time for depressed patients in order to clarify the determinants of depressive symptoms and, thus, reassure the patient and suggest nonpharmacologic measures. For example, insomnia, one of the most common complaints of depressed subjects, frequently resolves with behavioral measures ([@b22]).

ADRs before admission, but not in hospital ADRs, were negatively correlated with a discharge prescription of over 6 drugs. Although it is possible that ADRs occurring during stay may be due to the addition of new drugs need for the acute condition causing hospitalization, physicians should take into account their personal experience as a guide to the prescription at discharge. Indeed, while selected drugs are plagued by a higher incidence of ADRs, polypharmacy is the main risk factors for ADRs ([@b13]). Thus, attempts should be made to curtail inappropriate drug prescription. Unfortunately, such an attempt was made only for patients with a history of ADRs at home.

Surprisingly, internists and geriatricians had a comparable prescription practice. Theoretically, geriatricians should be more aware of problems related to polypharmacy. Present findings are in contrast with such an expectation and are not likely to be confounded by differences in age, comorbidity and functional status between patients admitted to medicine and geriatrics wards. However, the increase in the number of prescribed drugs at discharge could reflect, on average, an increased need in both geriatrics and internal medicine wards.

Limitations for this study deserve consideration. First, using data from 1998, results can not be inferred to the actual prescribing practice. However, the trend towards increased polypharmacy since 1998 have continued on account of evidence based medicine, and potential pitfalls of complex drug regimens in patients with multiple chronic conditions have been recently underlined ([@b35]; [@b6]). New diagnoses made during the stay might justify the increased drug prescription at discharge with regard to previous home therapy. Furthermore, it is possible that patients were not managed properly at home, thus causing their hospital admissions with the resultant addition of drugs to properly manage their diseases. We did not exclude people already taking 6 or more drugs at admission. This choice might have led to an overestimate of the prevalence of polypharmacy at discharge. We decided to leave these patients in our analyses because we could not assume that all of them would have been discharged with 6 or more prescription; furthermore the potential discrepancy is of only about 5%. Finally, some drugs might have been prescribed for a brief period to complete a short-term course. We could not correct our analysis for these potential confounders. However, the fact that most of newly prescribed drugs were devoted to treat chronic conditions suggests that the hospitalization resulted in a true and stable increase in drug use. This conclusion is further strengthened by the evidence that drug prescription at discharge increased for all the main disease categories.

###### 

Effects of hospitalization on the number of prescribed drugs in the whole population studied and in the most frequent disease groups

                            Number of drugs Median (interquartile range)                            
  ------------------------- ---------------------------------------------- ---------------- ------- ---------
  All patients (n = 2456)   3.0 (2.0--5.0)                                 4.0 (3.0--6.0)   −20.6   \<0.001
  CHF (n = 398)             5.0 (3.0--6.0)                                 6.0 (5.0--8.0)   −10.8   \<0.001
  NIDDM (N = 480)           4.0 (2.0--6.0)                                 5.5 (4.0--7.0)   −10.4   \<0.001
  COPD (N = 285)            4.0 (2.0--5.0)                                 5.0 (4.0--7.0)   −8.8    \<0.001
  CRF (N = 169)             5.0 (3.0--6.5)                                 6.0 (4.0--8.0)   −5.9    \<0.001

**Abbreviations**: COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; CRF, chronic renal failure; NIDDM, noninsulin dependent diabetes mellitus.

In conclusion, a trend is evident towards increasing drug prescription to the elderly discharged from general medicine and geriatrics wards. While we cannot clarify the mechanisms underlying this phenomenon, the risks related to polypharmacy in the elderly will never be sufficiently emphasized. Then, interventions should be promoted to identify the determinants and to assess the quality of this prescription practice. Furthermore, the general practitioner, who ultimately decides which therapy her/his patient will follow, should critically evaluate the discharge prescription and, if needed, discuss it with the hospital physician. Finally, while evidence-based guidelines are continuously produced to improve the treatment of more and more diseases, guidelines should also be implemented to provide the operational framework of the approach to the elderly and frail patient.
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